U.S. Energy Services Stock News

Globus Medical (NYSE:GMED) reports robust revenue growth supported by continued spending on research and development. The company secures new FDA clearances that expand its spine and orthopedic surgery product offering. Recent developments position Globus Medical as a higher growth, innovation driven investment profile compared with Medtronic. Globus Medical, a spine and orthopedics technology company, sits at the center of several long running trends in surgical care, including demand for...

Record highs in the Dow and S&P 500, a powerful chip stock rally, a stronger dollar and softer oil prices are reshaping where risk and opportunity may sit in large caps right now. To help make sense of it, this article focuses on three large cap blue chip stocks from our screener that appear especially exposed to these developments. These stocks may be affected in ways that could be either helpful or challenging, depending on your expectations and time frame. Each stock is backed by sizeable...

First Interstate BancSystem has delivered a 103.8% return over the past three years, and both the intrinsic value estimate from the Excess Returns model and the earnings multiples currently point to the stock trading at a discount to their fair value read, even though the broader valuation checks are more mixed. A 103.8% three year return sets a high bar, so any perceived discount now matters for investors who care about both price and durability of that rerating. Insider selling and recent...

Piper Sandler Companies (NYSE:PIPR) has appointed John D’Amico as a managing director in its restructuring group. D’Amico will focus on complex corporate restructurings and special situations within the firm’s advisory platform. The appointment expands the company’s leadership bench in an area that can be important during more uncertain economic periods. Piper Sandler enters this leadership change with its shares at $71.09 and a mixed recent track record, with the stock down 8.5% over the...

Over the last 7 days, the United States market has risen by 1.4%, contributing to a robust annual climb of 19%, with earnings forecasted to grow by 19% annually. In this environment, identifying stocks that are potentially trading below their true value can offer investors opportunities for growth as they align with the market's upward trajectory and anticipated earnings expansion.

Over the last 7 days, the United States market has risen by 1.4%, contributing to a 19% increase over the past year, with earnings expected to grow by 19% annually in the coming years. While the term 'penny stock' might seem outdated, it remains relevant as these smaller or newer companies can offer significant opportunities when backed by solid financials. In this article, we'll explore three penny stocks that demonstrate both balance sheet strength and potential for substantial returns,...

Weaker U.S. jobs data has taken some heat out of rate hike fears, lifted gold and reminded investors that policy signals can swing sentiment quickly. For dividend investors, that mix of softer growth signals, sticky inflation risks and another leg up in safe haven demand is a cue to stress test income holdings. This article looks at how that backdrop connects to a hand picked Dividend Stocks screener, focusing on three stocks that stand out for their mix of size, dividend profile and lower...

Mobility Global (MBGL) has just completed its spin off from S&P Global, with shares distributed to existing S&P Global investors and trading beginning on the New York Stock Exchange on July 1, 2026. See our latest analysis for Mobility Global. After the spin off, Mobility Global’s 1 day share price return declined 6.56% and its year to date share price return is down 5.69%. This suggests early trading pressure even as the stock joins multiple global indices and completes a broad board...

In late June 2026, Lantheus Holdings reported that the FDA issued a Complete Response Letter for its LNTH-2501 PET imaging kit for somatostatin receptor‑positive neuroendocrine tumors, citing unresolved third‑party manufacturing facility issues rather than concerns about the product’s safety, efficacy, or supporting data. Separately, the company was added to both the Russell 2000 Defensive Index and the Russell 2000 Growth‑Defensive Index, highlighting its growing profile within defensive...

Premium credit cards are turning into lifestyle passes, with American Express, Chase and rivals racing to win affluent cardholders through airport lounges, event access and higher tier perks. With annual fees at the top end now reaching hundreds of dollars, the gap between premium and mass market customers is widening, and fee income is becoming more concentrated among high spenders. This article looks at three stocks from our Premium Consumer Finance Stocks screener that appear especially...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

LiveRamp Holdings (RAMP) is drawing fresh attention after announcing a new integration with Adobe GenStudio for Commerce Media Networks, linking its commerce purchase data directly into Adobe’s agentic content supply chain. See our latest analysis for LiveRamp Holdings. LiveRamp Holdings’ integration news lands at a time when the stock’s recent momentum has been strong, with a 90 day share price return of 38.92% and a year to date share price return of 37.60%. At the same time, the 3 year...

Adobe Inc. ( NASDAQ:ADBE ) shareholders (or potential shareholders) will be happy to see that the Independent Director...

With weaker US jobs data, rising borrowing costs, and rate hike worries tugging at sentiment, many investors are rethinking how much risk they want to take. Defensive dividend stocks, with larger market caps, sturdy balance sheets, and a record of paying consistent income, can look relatively steady when growth stories feel less certain. This article explains how the latest macro signals around jobs, yields, and manufacturing might influence that corner of the market, and highlights 3 stocks...

Some Mineralys Therapeutics, Inc. ( NASDAQ:MLYS ) shareholders may be a little concerned to see that the President, Jon...

In late June 2026, Jack in the Box Inc. completed a US$500 million securitized debt refinancing and was reclassified across several Russell indices, including additions to the Russell Microcap and Russell 3000E families while exiting certain Russell 2000 defensive subsets. This combination of balance sheet reshaping and index reweighting altered how the company fits into benchmark portfolios and may change how both passive and active investors gain exposure to the stock. Next, we’ll examine...

ITG stock in focus after index additions ITG (ITG) is drawing fresh attention after its recent initial public offering and rapid inclusion in both the NASDAQ Composite Index and the NASDAQ Telecom Index, putting the new telecom infrastructure stock on more investor radars. See our latest analysis for ITG. Since listing at an IPO price of US$16.00, ITG’s latest close at US$15.46 reflects a 1 day share price return that declined 12.70% and a year to date share price return that declined 3.38%...

We note that the Lexeo Therapeutics, Inc. ( NASDAQ:LXEO ) Chief Medical Officer, Narinder Bhalla, recently sold US$99k...

Motorsport Games Inc. ( NASDAQ:MSGM ), might not be a large cap stock, but it saw a double-digit share price rise of...

The United States market has shown a positive trend, climbing 1.4% in the last week and 19% over the past year, with earnings anticipated to grow by 19% annually in the coming years. In this favorable environment, identifying stocks that are considered undervalued and have insider buying can be a strategic approach for investors looking to capitalize on potential growth opportunities.

Over the last 7 days, the United States market has risen by 1.4%, contributing to a notable 19% increase over the past year, with earnings expected to grow by 19% annually in the coming years. In this thriving environment, identifying stocks that may be trading below their estimated intrinsic value can offer investors potential opportunities for capitalizing on market inefficiencies.

The U.S. market has shown positive momentum, rising 1.4% over the last week and 19% over the past year, with earnings projected to grow by 19% annually. In this environment, growth companies with substantial insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business's operations and future prospects.

We feel now is a pretty good time to analyse Tenaya Therapeutics, Inc.'s ( NASDAQ:TNYA ) business as it appears the...

Over the last 7 days, the U.S. market has risen by 1.4%, contributing to a notable 19% increase over the past year, with earnings projected to grow annually by a similar rate in the coming years. For those interested in exploring smaller or newer companies, penny stocks—despite their somewhat outdated label—can still offer intriguing opportunities for growth and value. This article will explore several penny stocks that exhibit financial strength and potential for long-term success amidst...